Laird Norton Wetherby Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.07M | Buy |
31,425
+918
| +3% | +$95.1K | 0.13% | 148 |
|
|
2025
Q2 | $3.28M | Buy |
+30,507
| New | +$3.09M | 0.15% | 131 |
|
|
2024
Q4 | $2.28M | Sell |
25,574
-2,533
| -9% | -$223K | 0.11% | 180 |
|
|
2024
Q3 | $2.36M | Buy |
28,107
+576
| +2% | +$45.4K | 0.11% | 193 |
|
|
2024
Q2 | $2.12M | Sell |
27,531
-889
| -3% | -$65.1K | 0.1% | 204 |
|
|
2024
Q1 | $1.95M | Buy |
28,420
+297
| +1% | +$19.1K | 0.09% | 231 |
|
|
2023
Q4 | $1.63M | Sell |
28,123
-23
| -0.1% | -$1.23K | 0.08% | 246 |
|
|
2023
Q3 | $1.49M | Buy |
28,146
+433
| +2% | +$22.7K | 0.08% | 255 |
|
|
2023
Q2 | $1.5M | Sell |
27,713
-944
| -3% | -$49.3K | 0.08% | 257 |
|
|
2023
Q1 | $1.43M | Sell |
28,657
-480
| -2% | -$22.6K | 0.08% | 254 |
|
|
2022
Q4 | $1.35M | Buy |
29,137
+667
| +2% | +$28.9K | 0.09% | 260 |
|
|
2022
Q3 | $1.1M | Buy |
28,470
+604
| +2% | +$24.2K | 0.08% | 265 |
|
|
2022
Q2 | $1.04M | Buy |
27,866
+2,077
| +8% | +$84.5K | 0.07% | 288 |
|
|
2022
Q1 | $1.14M | Buy |
25,789
+2,151
| +9% | +$93.2K | 0.07% | 278 |
|
|
2021
Q4 | $1M | Sell |
23,638
-986
| -4% | -$41.4K | 0.06% | 322 |
|
|
2021
Q3 | $1.07M | Buy |
24,624
+639
| +3% | +$28.3K | 0.07% | 284 |
|
|
2021
Q2 | $1.03M | Buy |
23,985
+1,176
| +5% | +$49.5K | 0.06% | 289 |
|
|
2021
Q1 | $881K | Sell |
22,809
-98
| -0.4% | -$3.71K | 0.07% | 292 |
|
|
2020
Q4 | $824K | Sell |
22,907
-2,349
| -9% | -$84.7K | 0.06% | 318 |
|
|
2020
Q3 | $965K | Buy |
25,256
+3,406
| +16% | +$131K | 0.09% | 229 |
|
|
2020
Q2 | $768K | Sell |
21,850
-341
| -2% | -$12.3K | 0.07% | 260 |
|
|
2020
Q1 | $724K | Sell |
22,191
-1,126
| -5% | -$44K | 0.08% | 238 |
|
|
2019
Q4 | $1.05M | Buy |
23,317
+1,902
| +9% | +$79.6K | 0.1% | 208 |
|
|
2019
Q3 | $871K | Buy |
21,415
+527
| +3% | +$22.3K | 0.09% | 232 |
|
|
2019
Q2 | $898K | Buy |
20,888
+513
| +3% | +$19.7K | 0.1% | 224 |
|
|
2019
Q1 | $782K | Buy |
20,375
+2,697
| +15% | +$103K | 0.1% | 236 |
|
|
2018
Q4 | $625K | Buy |
17,678
+194
| +1% | +$7.04K | 0.09% | 262 |
|
|
2018
Q3 | $673K | Buy |
17,484
+681
| +4% | +$23.8K | 0.08% | 274 |
|
|
2018
Q2 | $549K | Buy |
16,803
+1,429
| +9% | +$43.1K | 0.07% | 315 |
|
|
2018
Q1 | $420K | Buy |
15,374
+770
| +5% | +$20.9K | 0.06% | 395 |
|
|
2017
Q4 | $362K | Buy |
14,604
+623
| +4% | +$17.2K | 0.05% | 431 |
|
|
2017
Q3 | $408K | Buy |
13,981
+193
| +1% | +$5.33K | 0.06% | 385 |
|
|
2017
Q2 | $382K | Buy |
13,788
+523
| +4% | +$13.9K | 0.07% | 370 |
|
|
2017
Q1 | $330K | Buy |
13,265
+835
| +7% | +$20.3K | 0.06% | 402 |
|
|
2016
Q4 | $269K | Sell |
12,430
-1,370
| -10% | -$29.9K | 0.05% | 434 |
|
|
2016
Q3 | $328K | Buy |
13,800
+439
| +3% | +$10.5K | 0.07% | 357 |
|
|
2016
Q2 | $312K | Buy |
13,361
+1,352
| +11% | +$29.2K | 0.07% | 339 |
|
|
2016
Q1 | $226K | Buy |
12,009
+635
| +6% | +$11.2K | 0.05% | 402 |
|
|
2015
Q4 | $210K | Buy |
11,374
+225
| +2% | +$4.03K | 0.05% | 416 |
|
|
2015
Q3 | $183K | Buy |
11,149
+509
| +5% | +$8.7K | 0.05% | 422 |
|
|
2015
Q2 | $188K | Buy |
+10,640
| New | +$190K | 0.05% | 434 |
|
Other funds holding BSX
